Vivo Capital, LLC Q1 2022 Filing
Filed May 13, 2022
Portfolio Value
$1.5T
Holdings
54
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (54 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HRMYHarmony Biosciences Holdings Inc | 4,570,148 | $222.3B | 15.31% | |
| 2 | —New Frontier Health Corp | 14,300,000 | $170.9B | 11.77% | |
| 3 | TILInstil Bio Inc | 12,486,787 | $134.2B | 9.24% | |
| 4 | OPHTEURIveric Bio Inc | 6,431,940 | $108.3B | 7.45% | |
| 5 | —Sierra Oncology, Inc | 3,329,511 | $106.7B | 7.35% | |
| 6 | ALXOALX Oncology Holdings Inc | 4,220,048 | $71.3B | 4.91% | |
| 7 | ASNDAscendis Pharma A/S | 442,502 | $51.9B | 3.58% | |
| 8 | AMRSEURAmyris, Inc | 11,642,195 | $50.8B | 3.50% | |
| 9 | TARSTarsus Pharmaceuticals Inc | 2,987,331 | $50.2B | 3.46% | |
| 10 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 2.63% | |
| 11 | VTYXVentyx Biosciences Inc | 1,921,726 | $26.1B | 1.80% | |
| 12 | VRDNViridian Therapeutics Inc | 1,300,000 | $24.0B | 1.66% | |
| 13 | KALVKalVista Pharmaceuticals Inc. | 1,533,559 | $22.6B | 1.56% | |
| 14 | TCE2Celldex Therapeutics Inc | 628,356 | $21.4B | 1.47% | |
| 15 | GONGeron Corp | 15,238,095 | $20.7B | 1.43% | |
| 16 | AVDLAvadel Pharmaceuticals PLC | 2,937,093 | $20.1B | 1.38% | |
| 17 | RLMDRelmada Therapeutics Inc | 705,882 | $19.1B | 1.31% | |
| 18 | —Impel NeuroPharma Inc | 2,884,789 | $18.4B | 1.27% | |
| 19 | —Genetron Holdings Ltd | 7,411,577 | $16.2B | 1.12% | |
| 20 | IOBTIO Biotech Inc | 3,015,545 | $16.0B | 1.10% | |
| 21 | VERAVera Therapeutics Inc | 666,666 | $15.7B | 1.08% | |
| 22 | ACRSAclaris Therapeutics, Inc. | 898,631 | $15.5B | 1.07% | |
| 23 | COGTCogent Biosciences Inc | 1,920,941 | $14.4B | 0.99% | |
| 24 | 290AChinook Therapeutics Inc | 872,151 | $14.3B | 0.98% | |
| 25 | VRNAVerona Pharma PLC | 2,749,918 | $13.7B | 0.94% | |
| 26 | WHWKAadi Bioscience Inc | 772,416 | $13.1B | 0.90% | |
| 27 | MRUSMerus NV | 442,000 | $11.7B | 0.80% | |
| 28 | IOVAIovance Biotherapeutics Inc | 655,057 | $10.9B | 0.75% | |
| 29 | BOLT1EURBolt Therapeutics Inc | 3,871,291 | $10.6B | 0.73% | |
| 30 | —Minerva Surgical Inc | 2,215,667 | $10.0B | 0.69% | |
| 31 | LEGNLegend Biotech Corp Sponsored | 244,375 | $8.9B | 0.61% | |
| 32 | CDXSCodexis, Inc | 388,144 | $8.0B | 0.55% | |
| 33 | ZLABZai Lab Ltd ADR | 181,577 | $8.0B | 0.55% | |
| 34 | TERNTerns Pharmaceuticals Inc | 2,675,133 | $7.9B | 0.55% | |
| 35 | DSGNDesign Therapeutics | 476,589 | $7.7B | 0.53% | |
| 36 | ALGSAligos Therapeutics Inc | 3,547,030 | $7.6B | 0.53% | |
| 37 | OLMAOlema Pharmaceuticals Inc | 1,689,515 | $7.2B | 0.50% | |
| 38 | SERASera Prognostics Inc | 1,856,011 | $7.0B | 0.48% | |
| 39 | BLUBellus Health Inc | 1,017,152 | $7.0B | 0.48% | |
| 40 | ARWRArrowhead Pharmaceuticals Inc | 137,411 | $6.3B | 0.44% | |
| 41 | NKTXNkarta Inc | 512,225 | $5.8B | 0.40% | |
| 42 | DYNDyne Therapeutics Inc | 577,642 | $5.6B | 0.38% | |
| 43 | —Satsuma Pharmaceuticals Inc | 1,232,394 | $4.7B | 0.32% | |
| 44 | MREOMereo Biopharma Group PLC | 3,795,225 | $4.3B | 0.29% | |
| 45 | —Dice Therapeutics Inc | 163,136 | $3.1B | 0.21% | |
| 46 | CMPXCompass Therapeutics Inc | 2,000,000 | $2.7B | 0.19% | |
| 47 | FIXXEURHomology Medicines, Inc. | 853,143 | $2.6B | 0.18% | |
| 48 | —Aslan Pharmaceuticals Ltd | 2,840,909 | $2.6B | 0.18% | |
| 49 | GRCLGracell Biotechnologies Inc | 961,359 | $2.2B | 0.15% | |
| 50 | —Zymeworks Inc | 286,064 | $1.9B | 0.13% | |
| 51 | —Elevation Oncology Inc | 496,844 | $1.3B | 0.09% | |
| 52 | DTILPrecision Biosciences Inc | 140,255 | $432.0M | 0.03% | |
| 53 | —Metacrine Inc | 146,426 | $89.0M | 0.01% | |
| 54 | CLDNEUREiger BioPharmaceuticals Inc | 4,166 | $35.0M | 0.00% |